Pfizer Is Worst-Performing US Large-Cap Pharma Stock This Year, Its Investment Case Is Complex Yet Rewarding
Credit Suisse has initiated coverage on Pfizer Inc (NYSE:PFE) with an Outperform rating and a price target of $55. The analyst…
Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock
Credit Suisse has initiated coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating and a price target of $170. The…
Credit Suisse Sets Bearish Tone For Amgen; Says Current Setup Not Ideal For Growth
Credit Suisse has initiated coverage on Amgen Inc (NYSE:AMGN) with an Underperform rating and a price target of $240. The analysts say…
Alibaba Will Be Critical Beneficiary Of China’s Reopening and Economic Recovery, Analysts Say
Mizuho analyst James Lee maintained Alibaba Group Holding Ltd (NYSE:BABA) with a Buy and cut the price target from $160 to $155.…
Credit Suisse Sees Uncertainty On New Product Launch Execution & Growth For Bristol Myers
Credit Suisse has initiated coverage on Bristol-Myers Squibb Co (NYSE:BMY) with a Neutral rating and a price target of $78. The analysts…
Palo Alto Well-Positioned To Drive Strong Growth, Profitability And FCF, Analysts Say
Barclays analyst Saket Kalia maintained Palo Alto Networks Inc (NASDAQ: PANW) with an Overweight and
Credit Suisse Says AbbVie’s Humira Patent Cliff Could Provide Momentum to Boost Growth
Credit Suisse has initiated coverage on AbbVie Inc (NYSE:ABBV) with an Outperform rating and a price target of $170. AbbVie stands on…
Eli Lilly Is Best-In-Class Growth, Says Analyst While Initiating Coverage
Credit Suisse has initiated coverage on Eli Lilly And Co (NYSE:LLY) with an Outperform rating and a price target of $395. Management…
Credit Suisse Believes In This Pharma Giant’s Low Risk Growth Against Uncertain Backdrop
Credit Suisse has initiated coverage on Merck & Co Inc (NYSE:MRK) with an Outperform rating and a price target of $120. The…
Gap Faces Holiday Uncertainty Heading Into Q4, Says Analyst
Telsey Advisory Group analyst Dana Telsey reiterated with a Market Perform rating on the shares of Gap Inc (NYSE:GPS) and raised the…